ZC3H18 and breast cancer: Indeed, ZC3H18 depletion enhanced E2F1 binding to DNMT1 in ovarian cancer but not in breast cancer cells (Supplementary Fig. 7b, c), suggesting that loss of ZC3H18 leads to E2F1-DNMT1 repressor complex formation in ovarian cancer cells.